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Sepsis is responsible for 75 percent of late deaths following major thermal injury or traumatic
injury. Efforts to prevent and/or control sepsis should include an understanding of normal host
resistance, proper resuscitation techniques, and nutritional support. Recent studies identifying T
suppressor cell abnormalities in burn patients and macrophage defects in trauma patients are
presented in this paper. Concluding remarks regarding future directions for research and therapy
in this area are also made.
INTRODUCTION
As surgical skills have improved over the last several decades, surgeons have
operated upon and cared for increasingly critically ill patients. Despite major advances
in a number of areas, the problems of infection and sepsis continue to plague us.
Although neurologic injury continues to account for approximately 50 percent of
deaths following major trauma, sepsis has been identified as a cause of death in 75
percent of late non-neurologic deaths [1]. If a patient survives inhalation injury
following a major burn, sepsis constitutes the most significant threat to life thereafter
[2]. In these two high-risk groups, sepsis is associated with a 50 percent mortality,
which is increased to 75 percent ifmultiple organ failure supervenes [3].
A number of factors must be considered when evaluating the risk of sepsis for the
trauma patient. This article will attempt to highlight the following areas: normal host
resistance, specific studies in trauma and burn patients, and future directions for
therapy directed at preventing and/or treating sepsis. The area of host resistance and
immunology has been rapidly changing with significant advances over the past few
years. Because of the complexity of this area and the controversial nature of some of
the data in the current literature, this review will attempt to aid the reader in
developing a basic understanding of this field and a knowledge of what is currently
accepted.
NORMAL HOST RESISTANCE
Host factors involved in defense against bacterial infection have classically been
divided into nonspecific and specific factors. A brief outline of these factors is offered
below.
Nonspecific Factors
Some ofthe nonspecific factors that are involved in host defense include phagocyto-
sis, complement, age, mechanical barriers, nutrition, interferon, hormones, fibronec-
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tin, and the coagulation-fibrinolytic system. Due to limitations ofspace, only phagocy-
tosis will be discussed in detail.
Phagocytosis consists ofa series ofwell-defined steps that occur in series as follows:
(1) chemotaxis, or drawing of white cells into the area of bacterial infection;
(2) opsonization, the process by which bacteria are made more susceptible to
ingestion; (3) ingestion of the bacteria by neutrophils; and, finally, (4) killing of
bacteria occurs in several fashions (oxygen-dependent and oxygen-independent mech-
anisms). The ability of a white cell to migrate toward a stimulus can be measured in
several systems and has been shown to be abnormal in patients undergoing major
surgery or following major trauma [4]. The entire process ofphagocytosis is clearly a
complex one and is well summarized in recent reviews by Cates [5] and by Johnston
and Stroud [6].
Specific Immune Factors
The major components of the specific immune system are as follows: the bursa-
equivalent (B) cells, which differentiate to plasma cells and are primarily responsible
for the production of immunoglobulins or antibody; the thymus-derived (T) cells that
are responsible for cell-mediated interactions between macrophages and B cells; and
the population of accessory adherent cells consisting of wandering and fixed macro-
phages (MO), which have a diverse number of functions. All of these cells produce
humoral components and have cellular interactions which are extremely complex.
In-depth analysis is beyond the scope ofthis review, but an excellent recent summary
by Paul et al. is available [7].
PremorbidStatus
It is critical for the surgeon to evaluate carefully the various medical diseases that
affect host resistance. There are a number ofdiseases that depress neutrophil function
and therefore tend to inhibit phagocytosis (e.g., diabetes). Major trauma and burns
have been shown to be associated with the increased riskofsepsis, and these conditions
will be covered in more detail later. Other diseases putting patients at risk are
malignancy, cirrhosis, renal transplantation, atherosclerotic cardiovascular disease,
and malnutrition.
Although the term reticuloendothelial system has become relatively outmoded, the
system of fixed and wandering monocyte macrophages (MO) are -till critical in host
defense. Obviously, previous splenectomy leads to abnormalities in_this area, particu-
larly in children [8], and recent studies havedemonstrated a monocytedefect following
splenectomy [9]. Patients with diseases such as lymphoma, sarcoidosis, sickle cell
disease, various autoimmune diseases, and previous irradiation to the lymphoid system
are all susceptible to phagocytic defects in the MO system and should be treated with
special care when undergoing surgery or following trauma.
Surgical Risk Factors
In addition to the above premorbid factors, there are a number of negative factors
involved in trauma patients that will decrease host resistance. Local wound factors that
interfere with host resistance include necrotic tissue, inadequate wound perfusion or
oxygenation, retained foreign body or suture material, and undrained hematoma or
seroma. It follows that the surgeon must be gentle with tissue, maximize debridement
of necrotic tissue, and optimize oxygenation and perfusion of surgical wounds.
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Although the clinical suspicion that shock places patients at risk for sepsis has been
held for some time, there are only a few studies that support this [10]. Steroids inhibit
the inflammatory response of white cells and have been associated with increased
mortality from sepsis in several settings. Dextran, stroma-free hemoglobin, fibrin
debris, and transfusion reactions may also inhibit the function of fixed phagocytic
cells.
A number ofauthors have looked at the interaction ofhost resistance and nutritional
status [4]. Meakins and his group have shown that anergy occurs frequently in elective
surgical patients and that this defect in delayed hypersensitivity can be either partially
or completely restored by aggressive nutritional support pre-operatively [11]. Follow-
ing major thermal injury or major trauma, caloric requirements may be as high as
5,000 kilocalories per day. Aggressive nutritional support with a combination of
parenteral and enteral nutrition is critical to decrease the risk of sepsis and its
associated mortality [12]. An excellent review of this entire field is available for those
who wish to pursue this matter further [13].
STUDIES IN TRAUMA PATIENTS
Extensive studies have been performed over the last several years on the interrela-
tionship of host defenses and trauma. A large body ofdata on host resistance surrounds
patients following major thermal injury or major trauma, and therefore some
comments will be made regarding these two entities.
Major Thermal Injury
It has been well documented in recent years that burn patients are among the most
susceptible to sepsis and have the largest number of abnormalities in host resistance
[14]. Obviously a major burn leads to disruption in the skin as a mechanical barrier,
thereby destroying the low moisture and natural antimicrobials produced by the
end-organs in the skin. If inhalation injury is present, mucous membranes in the
respiratory tract are disrupted from a chemical tracheobronchitis, resulting in dysfunc-
tion of ciliary and alveolar macrophage with resultant pulmonary sepsis. In addition,
there are problems in the phagocytic system with decreased cellular mobilization and
intracellular killing of bacteria [15]. Delayed hypersensitivity is depressed, and more
recently defects in specific immune function have been identified [16].
For those burn patients who do not die of inhalation injury, 75 percent of the late
mortality is due to sepsis [1]. Previously we evaluated, following thermal injury, 24
patients with a mean age of 45, a mean burn size of 40 ± 13 percent, halfof whom had
inhalation injury. Twelve of these patients developed severe sepsis with a mortality of
66 percent, whereas the other group had no major septic episodes. When T cells from
these patients were stimulated with phytohemagglutinin (PHA, a plant mitogen), the
septic group had major depression of PHA response at five to seven days while the
nonseptic patients had no depression or an elevation of the PHA response [17]. We
hypothesized that one possible cause for this abnormality in the septic patients was a
relative increase in T suppressor cell activity. To test this hypothesis, a mixed
lymphocyte culture system was utilized in which the effect of burn patients' T cells and
burn patients' cells depleted of T cells (by a sheep red blood cell rosette technique)
were added to a normal highly responsive one-way mixed lymphocyte response
(MLR). Whereas the burn patient T-cell populations were 75 percent suppressive at
five to seven days post-burn (coinciding with the PHA nadir), the T-cell-depleted
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populations had little or no suppression of the normal MLR at this time. This was
putative evidence that there was an increase in T suppressorcell activity at five to seven
days following thermal injury [18].
These abnormalities are interesting to immunologists, but it is difficult for clinicians
to utilize them since the results take five to seven days to process. In a corollary
observation, however, it was noted that red debris appeared on the Ficoll-Hypaque
lymphocyte separation gradients in the layer where the mononuclear cells normally
sediment. This observation was noted in all patients with sepsis, who had a 66 percent
mortality, and in none of the patients who did not develop sepsis [19]. Utilizing this
observation, it may eventually be possible to predict those burn patients at risk for
life-threatening sepsis. More recently, using a murine burn model in our laboratory, we
have been able to demonstrate the elaboration ofa suppressor effector factor by T cells
[20] and depressed production of interleukin-1 by MO [21]. These data suggest that
there may be a macrophage defect that precedes the T-cell defect or perhaps even
induces the T-cell defect. Further work in this area will need to be done, but a lot has
been accomplished in the last few years and it is hoped that further advances in
immunology will allow prevention ofsepsis in this high-risk population.
Major Trauma
Studies of immunologic function and host resistance in major trauma patients have
not progressed so rapidly as in major burn patients because ofthe heterogeneity ofthe
trauma patient population. Nonetheless, several abnormalities have been identified,
which suggest that further study is warranted in this area. Abnormalities in chemo-
taxis and neutrophil function have been associated with serum inhibitory substances
that have recently been identified to be immunosuppressive polypeptides [22]. As
previously mentioned, abnormalities of T-cell function arising in patients two weeks
following splenectomy appear to be due to an inhibitory MO [9,23]. Miller et al. have
also recently identified decreases in the production of plasminogen activator and
increases in production of tissue thromboplastin factor in trauma patients [23].
Although trauma patients have depressed PHA responses compared to normals,
splenectomy patients have much more profound depressions in PHA responses,
occurring approximately fourteen to sixteen days post-operatively [9,23].
Further studies in this area were performed looking at the correlation ofshock and
sepsis following trauma. Twenty-one patients were studied following either major
surgery or significant trauma by combining pleural macrophage from chest tube
exudates with peripheral blood cells which had been filtered, removing the inhibitory
macrophages. Seventeen of the patients had minimal or no sepsis and had antibody-
forming cells in normal amounts (164/106 cells). In contrast, in patients with severe
sepsis, 60 percent of whom died, the antibody-forming cell response was profoundly
depressed (9.2/106 cells) [10].
In clinical studies of trauma patients we recently examined multiple demographic
and clinical variables to try to develop predictors ofoutcome. In the final analysis only
age, total injury severity score, the presence of shock on admission, and the length of
time in shock were predictive of increased risk for mortality [24]. In order to try to
identify trauma patients at risk, a study was recently designed to evaluate the
proliferative response of T cells to PHA following surgical trauma and to correlate
these results with post-operative infectious complications. Thirty-one patients were
evaluated, of whom 19 had complete data. Of eight patients who developed post-
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operative infections, two died, for a 25 percent mortality. The other eleven patients had
no infections and no mortality. Age was similar in both groups (mean, 50.5 years) but
average hospital stay was 31 days in the infected group and 12.5 days in the
non-infected group. PHA responses in the infected population dropped to 25 percent of
normal by day five to seven post trauma, whereas PHA responses were maintained at a
normal level in the uninfected patient population. When adherent cells were depleted
by adherence to plastic petri dishes, the PHA response in the infected group improved
from 25 percent of normal to 80 percent of normal at day five to seven following
trauma. The uninfected group, on the other hand, had a drop in the PHA response at
day five to seven when adherent cells were depleted [25]. The explanation for these
data is not completely clear, but one possible explanation is that there is a different
balance between inhibitory and facilitory macrophages in the two patient populations.
In this study the addition ofindomethacin to unfractionated cells in culture with PHA
led to increases in PHA responses in all groups, although this change was most
dramatic in the infected patient population at five to seven days following trauma.
Although these data are preliminary, several conclusions can be drawn. PHA
responses were depressed in some but not all patients after major injury, and patients
with depressed responses were far more likely to develop septic complications.
Depletion of adherent cells and/or addition of indomethacin to cell cultures improved
PHA responses significantly in vitro, suggesting a possible role for an inhibitory
macrophage in this setting [25]. The possibilities for future therapy in trauma patients
based on these data are exciting, but it is premature to contemplate such studies at this
point without further understanding of the complex immune abnormalities following
trauma.
FUTURE DIRECTIONS
Numerous possibilities loom on the horizon for further research and possible
therapeutic intervention in the critically ill trauma patient at risk for sepsis. Some
modalities have already been tested in humans, whereas others haveonly been tested in
animals or are conceptual possibilities. One very real therapeutic application of the
above-mentioned data is the increasing trend to conserve the spleen whenever possible
or to autotransplant splenic tissue in patients following splenic injury. There is good
experimental support for this approach [26] and a small body ofdata is accumulating
in humans. Following splenectomy in an animal model, glucan, a nonspecific immuno-
stimulant, has been shown to have a protective effect [27]. Glucan has also had a
protective affect in a model of Staphylococcus aureus bacteremia associated with
enhancement in serum lysozyme activity [28].
Significant interest has been generated by efforts to utilize antisera to E. coli J5 as a
vaccine. Enhanced opsonization and systemic clearance of bacteria resulted in
improved survival in an animal model [29], and suggestive evidence has been presented
utilizing this modality in humans [30]. Interest in improving opsonic function by
utilization of cryoprecipitate to reverse deficiencies in opsonic a2-surface binding
glycoprotein has been tested in trauma patients with some success [30]. The exact role
ofthis therapy is undetermined as yet.
Perhaps the most important caveat that needs to be delivered regarding immuno-
therapy and the future study of host resistance is that the host resistance system is a
very delicately balanced one. Efforts to stimulate the immune system may result in
autoimmune abnormalities which might be just as deleterious to the critically ill
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patient as the negative regulatory effects of immunosuppression. Although exciting
advances have been made in this field in the last ten years, our knowledge is still
incomplete, and therapeutic modulation of the immune system in humans must
proceed with great caution.
SUMMARY
This article has attempted to highlight some ofthe factors that lead to alterations in
host resistance in trauma patients. In caring for these patients a knowledge of normal
host resistance, including the nonspecific and specific immune systems, is critical.
Evaluation ofthe patient's premorbid status and specific injury is critical in identifying
a group of patients at high risk. In burn patients, T suppressor cells have been clearly
demonstrated in several systems, and recent works suggest that macrophage dysfunc-
tion early following burn injury may participate in the elaboration of suppressor T
cells. It is clear that, following splenectomy, mitogen response to PHA and plasmin-
ogen activator synthesis is depressed at two weeks post-operatively, and data suggest
that an inhibitory macrophage is involved in these abnormalities. In the trauma patient
the data are less clear because of the heterogeneity of this patient population, but
several recently described abnormalities have been outlined.
The trauma patient represents a significant challenge to the surgeon, not only in
terms of early diagnosis and management but in terms of the prevention of late
complications. It is suggested that aggressive resuscitation of shock, early support of
ventilatory function, attention to detail in aseptic technique, and appropriate nutri-
tional support may allow surgeons to decrease the mortality from sepsis following
trauma. This high-risk group of patients will continue to provide clinicians with a
challenge and research scientists with a number ofinteresting questions related to host
resistance and immunity. It is hoped that in the future we will be better able to prevent
sepsis in high-risk patients or treat it in those patients who do develop sepsis. Although
this goal may never be reached entirely, the extensive number ofexciting discoveries in
this area over the last few years suggests that it is a realistic goal.
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